FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

20 May 16

Cancer Genetics Announces $5 Million Registered Direct Offering (read more...)

- RUTHERFORD, N.J., May 20, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("Cancer Genetics" or the "Company"), an emerging leader (read more...)
17 May 16

Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma ™ (read more...)

- The Panel Provides Critical Genomic Information To Improve Patient Management & Guide Therapy Decisions FOCUS::Lymphoma™ panel is being used(read more...)

Events

Clinicians
Patients